The correct activation and differentiation of T lymphocytes results from the fine-tuning of intracellular signals delivered through co-engagement of the antigen-specific receptor and a series of accessory molecules simultaneously expressed on the cell surface. Among the lymphocyte accessory molecules (CD2, CD4, CD8, CD9, CD28, CD43, CD45, etc.), there are CD5 and CD6, two highly homologous representatives of the scavenger receptor cysteine-rich (SRCR) 1 superfamily (1, 2). The SRCR superfamily includes a heterogeneous group of soluble and/or membrane-associated receptors involved in the development of the immune system and in the regulation of both innate and adaptive immune responses (1) . This family is characterized by the presence of one or several repeats of a well conserved extracellular domain named SRCR, which was first reported at the C terminus of the macrophage type I scavenger receptor (SR-AI) (3) . CD5 and CD6 are the two representatives of the SRCR superfamily reported to be expressed on human lymphocytes. Both lymphocyte receptors are type I transmembrane glycoproteins with extracellular regions composed of three SRCR domains and cytoplasmic domains devoid of intrinsic catalytic activity but well adapted for signal transduction (4, 5) . The two molecules show a similar cell expression pattern, being expressed on thymocytes, mature T cells, B1a cells, and B chronic lymphocytic leukemia cells (2) , and their surface expression levels are also up-regulated by similar stimuli (6, 7) . The genes for CD5 and CD6 map to contiguous regions of human chromosome 11q12.2 and are supposed to have arisen from duplication of a common ancestral gene (8, 9) .
CD5 has been shown to behave as a dual receptor, which provides either positive or negative co-stimulatory signals depending on the cell type and the developmental stage (10) . To achieve this, engagement of different signaling molecules and cascades by CD5 (phosphatidylcholine-specific phospholipase C (PC-PLC), acidic sphingomyelinase (ASMase), casein kinase II (CKII), and phosphatidylinositol 3-kinase, Cbl, RasGAP, extracellular signal-regulated protein kinase/mitogen-activated protein kinase, etc.) have been reported (10) . Initial positive costimulatory properties on peripheral T cells were first reported for CD5, by using either soluble or solid phase-bound monoclonal antibodies (mAbs) (11) (12) (13) (14) . Later, data from CD5-deficient mice have shown that CD5 may also negatively regulate the signaling through the antigen-specific receptor complex on thymocytes and B1a cells (15, 16) . Subsequent studies (17) (18) (19) have highlighted the importance of CD5 in thymocyte develop-ment and of its cytoplasmic domain for the inhibitory function. It seems, however, that CD5 could exert negative effects on only one branch (Ca 2ϩ influx following phospholipase C-␥ activation) of the T cell receptor (TCR)-mediated signal, during CD5-mediated differentiation of double positive thymocytes (20, 21) . The influence of CD5 in the selection process of developing thymocytes has been shown to depend on the TCR/major histocompatibility complex/ligand affinity (15, 17, 18) . This, together with the fact that CD5 surface expression is developmentally regulated by TCR signals and TCR avidity (22) , has led to the notion that CD5 functions to fine-tune TCR signaling (18) . Whether this tuning is achieved by CD5 alone or in conjunction with other lymphocyte receptors remains to be ascertained. Recently, the synergistic effect on thymocyte-positive selection of the null mutations of CD5 and CD2, two associated molecules (23) , has been reported (24) . The identity and the role played by the CD5 ligand(s) are also a matter of controversy (2, 25) . A good candidate is, however, gp150 (26), a broadly distributed receptor that is expressed on thymic epithelial cells.
The precise function of CD6 in lymphocyte activation and differentiation still remains elusive. Available evidence indicates that it is an accessory molecule capable of providing co-stimulatory signals in mature T cells (27) (28) (29) (30) (31) (32) . The signaling pathway used by CD6 to influence T cell activation is, however, mostly unknown. It has been shown that CD6 becomes hyperphosphorylated on Ser and Thr residues (29, 33) and transiently tyrosine-phosphorylated after CD3 stimulation alone or by co-cross-linking of CD3 with either CD2 or CD4 (34, 35) . In B chronic lymphocytic leukemia cells, CD6 ligation protects from anti-IgM-mediated apoptosis through Bcl-2 induction (36) . A role for CD6 in thymocyte development has also been suggested. CD166/activated leukocyte cell adhesion molecule, a CD6 ligand, is expressed on thymic epithelium and mediates adhesion of thymocytes to it (37) (38) (39) . The correlation of CD6 expression with thymocyte-positive selection and resistance to apoptosis has also been reported (40) . Mice deficient for CD6 are not available yet, and the possibility that CD6 possesses negative regulatory properties similar to those reported for CD5 on thymocyte development still has to be evaluated.
CD5 has been found physically associated with the antigenspecific receptor present on B1a (B cell receptor) and T (TCR) cells (41, 42) , as well as with the surface receptors CD4 or CD8, CD2, and CD9 (23, 43, 44) . This positions CD5 as an important regulatory molecule relevant for T and B cell-mediated responses. In the CD6 case, no associations with other lymphocyte surface receptors have been reported up to now. The fact that CD5 and CD6 are closely related molecules, not only at structural but also at expression and functional level (2), prompted us to investigate a possible physical association between them. Here we present strong biochemical and microscopic evidence on the in vivo association and co-localization of CD5 and CD6 on the membrane of T lymphocytes. This suggests that they may constitute a functional unit subserving lymphocyte activation and differentiation processes. (45) . The Leu-1 and 161.8 mAbs were conjugated to cyanine 3 (Cy3) using the Cy3 mAb labeling kit (Amersham Biosciences). The FITC-conjugated goat anti-mouse polyvalent immunoglobulins (GAMIg-FITC) were from Sigma. Horseradish peroxidase (HRP)-conjugated streptavidin (SAv) was from Dako (Denmark). Tricolor-and Texas Red (TR)-conjugated SAv were from Caltag (Burlingame, CA). The generation of the rabbit polyclonal antiserum against the extracellular region of human CD5 has been reported elsewhere (46) . The anti-CD6 polyclonal antiserum was produced in our laboratory by immunizing rabbits for 2 weeks with four intramuscular injections (50 g each) of glutathione S-transferase (GST)-CD6cy in complete (first) and incomplete (next) Freund's adjuvant (Invitrogen). Biotinylation of mAbs and cell surface proteins was performed with EZ-Link sulfo-NHS-LC-LC-Biotin following the manufacturer's instructions (Pierce). Mowiol 4-88 was from Calbiochem, and poly-L-lysine (PLL) was from Sigma. The blue fluorescent cell tracker chloromethyl derivative of aminocoumarin (CMAC) was from Molecular Probes (Eugene, OR). Staphylococcal enterotoxin E (SEE) was from Toxin Technology (Sarasota, FL).
MATERIALS AND METHODS

Cells-Lymphocytes
CD5 and CD6 Expression Constructions-The cDNA used to amplify the cytoplasmic region of CD6 was obtained by retrotranscription of total mRNA from PBL with Superscript TM II RNase H Ϫ Reverse Transcriptase (Invitrogen) following the manufacturer's instructions. The GST-CD6cy construct codes for a fusion protein was composed of the GST protein fused in-frame to the CD6 cytoplasmic region (from Lys-427 to Ala-688). This was done by PCR amplification of CD6 cDNA with the sense/antisense oligonucleotide pair, 5Ј-AGCAGTCGACGAAAG-GAAAATATGCCCTCCCCGTA-3Ј and 5Ј-AAGAATGCGGCCGCTAG-GCTGCGCTGATGTCATCGT-3Ј, and further cloning into SalI-and NotI-restricted (Fermentas MBI, Vilnius, Lithuania) pGEX 4T2 expression vector (Amersham Biosciences AB).
The expression construct coding for wild-type CD6 (CD6.WT) was obtained by cloning SalI/EcoRI-and EcoRI/BamHI-restricted (Fermentas MBI) fragments corresponding to the extracellular and cytoplasmic regions of CD6, respectively, into SalI/BamHI-restricted pH␤APr-1-neo mammalian expression vector. The extracellular portion of CD6 was obtained by PCR amplification using the 5Ј-TCTCGTCGACATGTG-GCTCTTCTTCGGGAT-3Ј and 5Ј-AACTTCTTTGGGGATGGTGATGG-G-3Ј primers and the CD6-PB1 cDNA sequence cloned into pBJneo as a template (47) . The intracellular region of CD6 was obtained by PCR amplification of HUT78 cDNA with the 5Ј-GTCACTATAGAATCTTCT-GTG-3Ј and 5Ј-AAAGGATCCCTAGGCTGCGCTGATGTCATC-3Ј primers. The generation of expression constructs coding for CD5.WT and CD5.K384 stop molecules has been described elsewhere (48) . Immunoprecipitation-Aliquots of surface biotinylated cells were lysed for 30 min on ice with a buffer containing 10 mM Tris-HCl, pH 7.6, 140 mM NaCl, 5 mM EDTA, 140 mM NaF, 0.4 mM orthovanadate, 5 mM pyrophosphate, 1 mM phenylmethylsulfonyl fluoride, protease inhibitor mixture tablets (Complete TM , Roche Molecular Biochemicals), and either 1% Nonidet P-40 (Nonidet P-40) (Roche Molecular Biochemicals) or 1% Brij 96 (Fluka). After centrifugation at 12,000 ϫ g for 15 min at 4°C, the cell lysates were precleared by end-over-end rotation with 50 l of 50% protein A-Sepharose CL-4B beads (Amersham Biosciences AB). Immunoprecipitations were carried out by adding 3 g of mAb plus 20 l of 50% protein A-Sepharose beads and by rotating for 2 h at 4°C. The immune complexes were washed three times in lysis buffer with 1% detergent. For re-precipitation, the immune complexes were boiled for 5 min in lysis buffer containing 3% SDS. The eluate was recovered and diluted 9-fold with lysis buffer and then pre-cleared with 50 l of 50% protein A-Sepharose beads for 30 min. Proteins were re-precipitated with 5 l of anti-CD6 or -CD5 polyclonal rabbit antiserum plus 20 l of protein A-Sepharose beads for 90 min at 4°C. Re-precipitates were washed three times with 200 l of lysis buffer, eluted by boiling for 5 min in SDS sample buffer, and run on 8% SDS-PAGE. For immunodepletion experiments, surface-biotinylated HUT-78 cells were lysed with 1% Brij 96 and then sequentially immunoprecipitated (eight times) with anti-CD5 (Cris-1) or anti-CD6 (161.8) mAbs. Once depleted, the lysates were immunoprecipitated with the reverse mAb and reprecipitated as above with rabbit polyclonal antisera (5 l) against the depleted molecule.
Transfection of COS-7 Cells-Transient transfection into COS-7 cells
was performed by the diethylaminoethyl-dextran/Me 2 SO method as previously described (49) . Briefly, 2 g of plasmid DNA per 2 ϫ 10 5 cells in a 9-cm 2 dish were used. The cells were harvested ϳ48 h after transfection and then surface-biotinylated and lysed with lysis buffer containing 1% Brij 96 as indicated above.
Western Blot Analysis-Samples resolved by 8% SDS-PAGE were electrophoretically transferred (at 0.4 A, 100 V for 1 h) to nitrocellulose membranes (Bio-Rad). Filters were blocked for 30 min at 37°C with 5% non-fat milk powder in phosphate-buffered saline (PBS) and then incubated for 30 min at room temperature with a 1/1000 dilution of HRPSAv in blocking solution. After three washes with PBS plus 0.1% Tween 20, the membranes were developed by chemiluminescence with SuperSignal West Dura Extended Duration Substrate (Pierce) and exposure to X-Omat TM films (Eastman Kodak). Capping-All procedures were performed at 4°C unless otherwise indicated. 1 ϫ 10 6 PBL were incubated for 10 min with saturating amounts of biotinylated anti-CD6 (SPV L14.2) or anti-CD5 (Cris-1) mAbs. After washing with ice-cold PBS plus 0.1% sodium azide, cells were incubated with saturating doses of TR-SAv for 10 min at 4°C. For capping to proceed, cells were then incubated at 37°C for 30 min. The reaction was stopped by adding ice-cold PBS/azide. Next, the cells were transferred onto PLL-coated coverslips and stained for 30 min with FITC-conjugated anti-CD5, -CD6, or -CD43 mAbs before fixation with PBS 2% paraformaldehyde. After washing twice, the coverslips were transferred onto Mowiol-treated glass slides, and visualized in a confocal spectral microscope (Leica Microsystems Heidelberg GmbH, Mannheim, Germany). The images were analyzed with the Image Processing Leica confocal software and 6 PBL (in 300 l of PBS) were transferred onto PLL-coated coverslips for 30 min at room temperature. After blocking with 1% heat-inactivated rabbit serum for 10 min at room temperature, cells were incubated for 15 min at 4°C with saturating amounts of FITC-(donor) and Cy3-labeled (acceptor) antibodies, either alone or mixed. Cells were then rinsed twice for 5 min at 4°C with PBS and fixed with PBS, 2% paraformaldehyde for 10 min at room temperature. After washed twice, the coverslips were transferred onto Mowiol-treated glass slides.
FRET measurements were based on the sensitized emission method (50, 51) with minor modifications for the confocal microscope. A Leica TCS SL laser scanning confocal spectral microscope (Leica Microsystems) equipped with argon and green HeNe lasers, ϫ100 oil immersion objective lens, and triple dichroic filter (488/543/633 nm) was used. To measure FRET, three images were acquired in the same order in all experiments as follows: 1) the FITC channel (absorbance 488 nm and emission 500 -555 nm), 2) the FRET channel (absorbance 488 nm and emission 590 -700 nm), and 3) the Cy3 channel (absorbance 543 nm and emission 590 -700 nm). Background was subtracted from images before FRET calculations. Control and experiment images were taken under the same conditions of photomultiplier gain, offset, and pinhole aperture. The crossover of donor and acceptor fluorescence through the FRET filter is a constant proportion between the fluorescence intensity levels of donor and acceptor and their bleed through. In order to calculate the spectral bleed through of the donor and acceptor through the FRET filter, images of cells labeled only with FITC-conjugated mAb and cells labeled only with Cy3-conjugated mAb were also taken under the same conditions as for the experiments. Fluorescence Analysis of Cell Conjugates-T cell-APC cell conjugates were generated by using V␤8 TCR-expressing Jurkat cells (J77c120) and the human B cell line Raji in the presence or absence of SEE as described previously (52) . Jurkat J77 cells were loaded with 10 M CMAC for 20 min at 37°C. Raji cells (5 ϫ 10 6 cell/ml) were resuspended in Hanks' balanced salt solution and incubated for 20 min in the presence or absence of 5 g/ml of SEE. J77 cells (5 ϫ 10 4 cell/well) were mixed with an equal number of Raji cells in a final volume of 600 l and incubated for 30 min before plating onto PLL-coated slides in flatbottomed 24-well plates (Costar Corp.). Cells were allowed to settle for 10 min at 37°C, fixed for 5 min in PBS 2% formaldehyde, and blocked with 100 g/ml human IgG (Sigma) before staining with the appropriated mAb plus FITC-GAMIg. Cells were observed by a DMR photomicroscope (Leica) with ϫ63 and 100 oil immersion objectives. Images were acquired using the Leica QFISH 1.0 software. Conjugates were first identified by directly observing both cell morphologies under differential interference contrast and blue fluorescent CMAC-labeled J77 cells.
RESULTS
The CD5 and CD6 Surface Receptors Co-precipitate in Normal and Leukemic Human T Lymphocytes-
The possible membrane association of CD5 and CD6 was explored by co-immunoprecipitation experiments of biotin-labeled surface proteins solubilized under different detergent conditions (either 1% Brij 96 or 1% Nonidet P-40). The presence of CD6 in CD5 immunoprecipitates was investigated by re-precipitation with a CD6-specific rabbit polyclonal antiserum. Conversely, a similar reprecipitation procedure was used to investigate the presence of CD5 in CD6 immunoprecipitates. Experiments performed with the human leukemic T cell line HUT-78 showed 105-130-kDa bands in CD5 immunoprecipitates from Brij 96 but not Nonidet P-40 lysates (Fig. 1A) . No similar bands were detected after CD6 re-precipitation of HLA class I and CD3 immunoprecipitates from Brij 96 lysates of biotin-labeled HUT-78 cells (Fig.  1B) . The bands observed agreed with the reported molecular mass of CD6, for which an un-phosphorylated 105-kDa form exists that rapidly changes to a phosphorylated 130-kDa form by exposure to serum or activators of protein kinase C (29, 33) . Conversely, a 67-kDa band, probably corresponding to CD5, was observed after re-precipitating CD6 immunoprecipitates with a CD5-specific polyclonal antiserum (Fig. 1A) . Depletion experiments showed that removal of either CD5 or CD6 by sequential immunoprecipitations abrogated the co-precipitation of the two molecules (Fig. 1C) , thus confirming that the 67 and 105-130 kDa bands detected by our polyclonal antisera are specific and almost certainly correspond to CD5 and CD6, respectively. Further experiments performed with surface-biotinylated thymocytes and lymph node cells (Fig. 1D) demonstrated the association of CD5 and CD6 on normal cell types.
Physical Linkage between CD5 and CD6The Association of CD5 and CD6 Is Independent of Co-expression of Other Lymphocyte Surface Receptors and of the Integrity of the CD5 Intracellular Region-CD5
is known to associate with other lymphocyte receptors (CD2, CD3, CD4, CD8, and CD9) under Brij 96-mediated cell membrane solubilization conditions (23, 43, 44) . Therefore, we used a heterologous cell environment to investigate whether CD5 and CD6 co-precipitation was either direct or mediated by an interposed lymphocyte surface molecule. For this purpose, COS-7 cells were transfected with wild-type CD5 alone or in combination with wild-type CD6 and then surface-biotinylated before lysis with 1% Brij 96. As shown in Fig. 2 , we detected a 130-kDa band in CD5 immune complexes only when the cells were co-transfected with CD5.WT and CD6.WT. This result indicates that the bands detected in our re-precipitation studies correspond to CD6 and that the association of CD5 and CD6 is unlikely to be mediated by other lymphocyte surface antigens previously reported to be associated with CD5. The relevance of the intracellular region of CD5 for the association with CD6 was also investigated by performing similar re-precipitation studies in COS-7 cells transfected with a cytoplasmic tail-less CD5 form (CD5.K378 Stop ). This truncated CD5 form was also able to co-precipitate CD6 (Fig. 2) , indicating that the deleted cytoplasmic region (from Lys-378 to Leu-471) is dispensable for the association of CD5 with CD6.
Measurement of CD6 and CD5 Association by FRET-To circumvent possible detergent-based artifacts, FRET microscopy analysis, a method that can detect molecular proximity between two proteins with a resolution of 10s of Ångstroms, was performed on living lymphocytes (51) . We utilized Cy3-labeled anti-CD5 mAb as acceptor and a series of FITC-conjugated mAbs against CD6, CD3, and CD43 as donor. The FRET images obtained for the different pairs of mAbs used are shown in Fig. 3A . Positive FRET between FITC-anti-CD6 and Cy3-anti-CD5 mAbs was found, thus confirming the association lysis buffer, split in two, and then subjected to several rounds (1, 3, and 8 times) of immunoprecipitation with either anti-CD6 (161.8) or anti-CD5 (Cris-1) mAbs. A second immunoprecipitation with either anti-CD5 or anti-CD6 mAbs was carried out only in the indicated samples. All the immunoprecipitates were re-precipitated with rabbit polyclonal antisera against either CD6 or CD5. Detection of biotinylated proteins in re-precipitates was done by HRP-SAv and enhanced chemiluminescence after running in 8% SDS-PAGE under reducing conditions and subsequent transfer to nitrocellulose membranes. D, co-precipitation of CD5 and CD6 in thymocytes and lymph node cells. Samples of thymocytes (2 ϫ 10 8 ) and lymph node cells (1 ϫ 10 8 ) were surface-biotinylated and analyzed as described in A.
FIG. 1. CD6 and CD5 co-precipitates from Brij 96 lysates of normal and leukemic human T cells.
A, co-precipitation of CD5 and CD6 from human leukemic T cells. 25 ϫ 10 6 HUT-78 cells were surfacebiotinylated and lysed with either 1% Nonidet P-40 or Brij 96 lysis buffer. CD5 and CD6 proteins were immunoprecipitated (Ip) using specific mAbs (Cris-1 and 161.8, respectively) and re-precipitated (ReIp) with rabbit polyclonal antisera specific for either CD5 or CD6. Re-precipitates were run in 8% SDS-PAGE under reducing conditions and transferred to nitrocellulose. Biotinylated proteins were detected by HRP-SAv and enhanced chemiluminescence and exposure to x-ray films. B, specific association of CD5 and CD6. Brij 96 lysates from 25 ϫ Stop ), either alone or in combination. Transfected cells were surface-biotinylated, lysed with 1% Brij 96, and subjected to CD5 immunoprecipitation (Cris-1 mAb). Immune complexes were eluted and then re-precipitated with polyclonal rabbit anti-CD6 serum. Detection of biotinylated proteins was done by HRP-SAv and enhanced chemiluminescence after running in 8% SDS-PAGE under reducing conditions and subsequent transfer to nitrocellulose membranes.
data between CD5 and CD6 deduced by co-precipitation studies. In agreement with previous reports on the physical association of CD5 and the TCR-CD3 complex on the surface of T lymphocytes (42), we also observed FRET between FITC-anti-CD3 and Cy3-anti-CD5 mAbs. On the contrary, very low FRET was observed when FITC-anti-CD43 and Cy3-anti-CD5 mAbs were used, which agrees with our data showing lack of cocapping between CD5 and CD43 molecules (data not shown). As a control of optimal energy transfer, we included Cy3-anti-CD5 cross-linked with FITC-GAMIg. The efficiency of energy transference between FITC and Cy3 fluorochromes measured by calculating the sensitized FRET signal (FRET c ) on a pixelby-pixel basis is shown in Fig. 3B . The highest median E a value was observed by cross-linking Cy3-anti-CD5 with FITCGAMIg. The median E a values obtained for the combination of the Cy3-anti-CD5 plus FITC-anti-CD6 mAbs and Cy3-anti-CD5 plus FITC-anti-CD3 mAbs were similar and reached statistical significance when compared with the combination used as negative control (Cy3-anti-CD5 plus FITC-anti-CD43 mAbs) (Fig. 3B) . Taken together, our FRET data indicate that CD5 is in close proximity not only with CD3 but also with CD6. The proportion of CD3 and CD6 molecules that associate with CD5 was estimated as 18 and 12%, respectively, from the numerical data presented in Fig. 3B (assuming 100% association for FITC-GAMIg/Cy3-␣CD5 and background levels for FITC-␣CD43/Cy3-␣CD5 E a values). This estimate is in agreement with data reported previously showing that 10 -20% of CD5 associates with CD3 in human T lymphocytes (53) .
CD5 and CD6 Partially Co-cap and Localize at the Immunological Synapse-To confirm further that CD5 physically associates with CD6 on the lymphocyte surface, we examined the ability of the two molecules to co-cap using double immunofluorescence. Co-capping was explored by incubating cells with biotin-labeled mAbs plus TR-SAv for 30 min at 37°C, followed by fixation and staining with FITC-conjugated mAbs. As shown in Fig. 4A , partial co-capping of CD5 and CD6 was observed independently of the direction explored. On the contrary, no cocapping of CD43 was found with CD6 ( Fig. 4A ) and CD5 (data not shown). The predicted presence of CD3 molecules on the caps induced with anti-CD5 mAbs (42) was confirmed (Fig. 4A) .
Next, we explored whether the down-modulation of the surface expression of one of the antigens (CD5 or CD6) reduced the surface expression of the other. For these purposes, lymphocytes were left overnight at 37°C in the presence or absence of unlabeled specific mAbs cross-linked with FITC-GAMIg. This resulted in complete loss of the corresponding antigen as assessed by comparing the green florescence emission (FL1) of mAb-modulated cells with that of unmodulated cells (data not shown). Then the cells were stained with biotinylated specific mAbs plus Tricolor-SAv and analyzed for red fluorescence (FL3). As shown in Fig. 4B , a reduction in CD5 surface expression of CD6-modulated cells was observed, compared with that of unmodulated cells. Similarly, a reduction in CD6 expression was also observed after mAb-induced modulation of CD5 (Fig.  4B) . Taken together, the co-capping and co-modulation results further extend our evidence on the physical association of CD5 and CD6 on the membrane of lymphocytes.
The recruitment of the CD5 and CD6 receptors to the same cap structures might be a nonspecific process related to membrane flow and cell motility. Therefore we decided to investigate the localization of the two molecules on more physiological supramolecular activation clusters (SMACs) formed at the interface of physical contact between T cells and APCs, also known as immunological synapse (IS). APC-T cell conjugates between Raji B cells and J77c120 Jurkat T cells were generated in the presence or absence of superantigen SEE. At 30 min, the localization of CD5 or CD6 at the cell interface was studied by staining with specific mAb plus FITC-GAMIg. As shown in Fig. 4C , both CD5 and CD6 accumulated at the contact zone between J77c120 and Raji cells in an antigen-specific manner. These data indicate that the association of CD5 and CD6 detected in resting lymphocytes is maintained when highly specialized and functionally relevant structures, such as IS, are formed.
DISCUSSION
Lymphocytes express numerous receptors, which continuously engage with ligands on cell surfaces. Some of these receptor/ligand pairs have co-stimulatory or inhibitory capacity. The dynamic cross-talk between these receptors ultimately governs the cell activation state. The present report shows that a fraction of the CD5 and CD6 lymphocyte receptors associate at the membrane of resting cells (thymocytes, lymph node cells, and PBL), likely constituting a functional unit. This is the first reported association for CD6 and provides further evidence on the relationship existing between the physiology of CD5 and CD6, not only at structural but also at functional level. Importantly, this association seems to be maintained following lymphocyte activation because they co-localize when more ordered structures, such as caps, are formed at the lymphocyte membrane. The cap structures consist of the assembly of receptors and signaling molecules involved in lymphocyte activation, which resembles that of SMACs at the interfaces of physical contact between T cells and APCs (54) . Although the biological significance of caps is questionable, that of the SMACs is indubitable. It is the TCR-mediated stimulation following contact between TCRs and major histocompatibility complex ligands expressed on APCs that leads to the formation of SMACs (54) . Thus, accumulation of CD5 and CD6 at this structure implies a relevant role for these molecules in the signaling processes taking place during T cell activation and differentiation. This is not surprising because both CD5 and CD6 have cytoplasmic tails that are well adapted for signal transduction. Furthermore, co-stimulatory properties on mature T cells have been reported for both molecules. Similarly, the certain role played by CD5 in thymocyte selection is probably shared by CD6, as deduced from the already available evidence (40) .
During lymphocyte maturation, developing T cell precursors are in continuous contact with stromal cells of the thymic microenvironment, and this physical contact is crucial for differentiation and selection. In this regard, it is known that both CD5 and CD6 are coordinately expressed from early (pro-T and double negative) stages of thymocyte development (22, 40) and possess ligands expressed on thymic epithelial cells (26, 37, 38) . This fact, together with the association data herein reported, may indicate that CD5 and CD6 are also functionally linked to influence thymocyte development and selection. This situation would be reminiscent of that reported previously (24) for CD2 and CD5. Both molecules present a similar pattern of expression during T cell ontogeny (40) , have been reported to be associated independently of CD3 (23) , and have synergistic effects on thymocyte-positive selection (24) . Therefore, the availability in the future of single (CD6) and double (CD5/ CD6)-deficient mice would help to confirm the possible functional linkage existing between CD5 and CD6 during intrathymic selection and to demonstrate whether they are connected with a common signaling pathway. Thus, if confirmed, it might indicate that redundant functional units (CD5/CD2 and CD5/ CD6) are used to securely drive the thymocyte selection process. This could explain why the extracellular region of CD5 is dispensable for the CD5-mediated down-regulation of TCR signaling during thymocyte development (25) . Although intact, the extracellular regions of CD2 and/or CD6 would interact with their respective ligands at the thymus and co-engage signals delivered through the associated CD5 molecules. In fact the deletion of the extracellular region of CD5 does not abrogate its association with CD2 (55) .
The data presented here indicate that the association of CD5 and CD6 is independent of both the co-expression of other lymphocyte receptors and most of the cytoplasmic region of CD5. These results, however, do not completely rule out the existence of interactions mediated through the cytoplasmic region, and further experiments are needed to fully map the CD5 and CD6 regions involved in this association. Interestingly, it has been reported recently (55) that the association of CD2 with CD5 is held at both the intra-and extracellular levels, and this could also be true in the association of CD5 and CD6. Our results also do not preclude that CD6 could associate independently with other lymphocyte surface receptors. This is illustrated by CD5, which has been reported to associate independently with CD2 and CD3 (23) and, herein, with CD6. The composition and organization of the plasma membrane is not homogenous, and these independent associations could take place at different membrane compartments, such as lipid rafts (56) . Indeed, it has been reported that a fraction of CD5 molecules resides in T cell rafts (57) . Our preliminary data, however, indicate that pretreatment of lymphocytes with methyl-␤-cyclodextrin, which disrupts lipid rafts microdomains, does not abrogate the association of CD5 with CD6.
In conclusion, the association of CD5 and CD6 suggests that both molecules may act coordinately during activation and/or differentiation of T lymphocytes by providing either similar or complementary intracellular signals. CD5 and CD6 share very similar extracellular regions but little homologous intracellular regions. Therefore, it can be hypothesized that they could recruit different signaling elements. The two molecules are rapidly phosphorylated on serine/threonine and tyrosine residues following engagement of the TCR-CD3 complex and then may interact with different intracytoplasmic molecules. Although not completely understood, the CD5 signaling pathway has been extensively studied (10) . On the contrary, there is still limited information available on CD6-mediated signaling. Thus, in light of the present report, it would be interesting to study not only the signaling capabilities of CD6 but also the possible cross-talk mechanisms existing between CD5 and CD6.
